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The gastrin/CCK receptor (CCK2R) mediates the physiological functions of gastrin in the
stomach, including stimulation of acid secretion and cellular proliferation and migration, but
little is known about the factors that regulate its expression. We identiﬁed endogenous CCK2R
expression in several cell lines and used luciferase promoter–reporter constructs to deﬁne the
minimal promoter required for transcription in human gastric adenocarcinoma, AGS, and rat
gastric mucosa, RGM1, cells. Consensus binding sites for SP1, C/EBP and GATA were essential
for activity. Following serum withdrawal from RGM1 and AR42J cells, endogenous CCK2R
mRNA abundance and the activity of a CCK2R promoter–reporter construct were signiﬁcantly
elevated. Transcription of CCK2R was also increased in AGS-GR and RGM1 cells by gastrin
through mechanisms partly dependent upon protein kinase C (PKC) and mitogen/extracellular
signal-regulatedkinase(MEK).GastrinsigniﬁcantlyincreasedendogenousCCK2Rexpressionin
RGM1 cells, and CCK2R protein expression was elevated in the stomach of hypergastrinaemic
animals. In mice with cryoulcers in the acid-secreting mucosa, CCK2R expression increased
progressively in the regenerating mucosa adjacent to the ulcer repair margin, evident at 6days
postinjuryandmaximalat13days.DenovoexpressionofCCK2Rwasobservedinthesubmucosa
beneaththerepairingulcercrater6–9dayspostinjury.Manyofthecellsinmucosaandsubmucosa
that expressed CCK2R in response to cryoinjury were identiﬁed as myoﬁbroblasts, since they
coexpressed vimentin and smooth muscle α-actin but not desmin. The data suggest that
increased CCK2R expression might inﬂuence the outcome of epithelial inﬂammation or injury
and that the response may be mediated in part by myoﬁbroblasts.
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Amidated peptides of the gastrin–cholecystokinin (CCK)
family exert their effects via two G-protein-coupled
receptors, the CCK1 receptor, which has high afﬁnity for
CCK, and the CCK2 receptor (CCK2R), which has high
afﬁnity for both peptides (Noble et al. 1999; Dufresne
etal.2006).TheCCK2R(formerlyCCKBR)wasoriginally
deﬁned in central nervous system (Innis & Snyder, 1980),
where it is widely distributed, notably in cerebral cortex
and striatum, and where CCK is likely to be the most
important endogenous ligand. In the periphery, the
CCK2R is located primarily on parietal cells (Kopin et al.
1992) and enterochromafﬁn-like (ECL) cells within the
gastricepithelium,whereitmediatestheactionsofgastrin
(Dockrayetal.2005),butexpressionhasalsobeenreported
on gastrointestinal smooth muscle cells (Reubi et al.
1997; de Weerth et al. 1997), pancreatic cells (Morisset,
2005; Cayrol et al. 2006) myenteric neurones (Mantyh
et al. 1994) and cells of the immune system (Mezey &
Palkovits, 1992; Iwata et al. 1996; Schmitz et al. 2001).
The main established physiological function of gastrin is
the regulation of gastric acid secretion by parietal cells,
principallyindirectly,throughhistaminereleasefromECL
cells (Dockray et al. 2005). Increasing evidence suggests
that direct activation of the parietal cell CCK2R may
be more important for parietal cell maturation and for
proliferation and migration of gastric epithelial cells than
foracutestimulationofgastricacidsecretion(Nagataetal.
1996; Koh et al. 1997; Friis-Hansen et al. 1998; Kirton
et al. 2002; Dockray et al. 2005; Dimaline & Varro, 2007).
ThephysiologicalsigniﬁcanceoftheCCK2Ronperipheral
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cells other than ECL cells and parietal cells remains to be
established.
There are a number of reports that in some clinical
or experimental situations, expression of the CCK2R
is augmented or induced in sites other than those
seen in physiological circumstances. Thus, expression
of the CCK2R was seen on proliferating cells in a
hypergastrinaemic transgenic mouse that has gastric
hyperproliferation (Nakajima et al. 2002) and in the
regenerative zone at the margins of experimentally
induced cryoulcers in rats (Schmassmann & Reubi,
2000). Upregulated CCK2R expression has also been
described in the epithelium of Barrett’s oesophagus
compared with normal oesophageal epithelium (Haigh
etal.2003)andinintestinalepitheliumofmicesubjectedto
γ-irradiation (Ottewell et al. 2006). These data suggest
that CCK2R expression may be upregulated during the
hyperproliferation seen in response to inﬂammation and
injury of gastrointestinal epithelia. Upregulation of the
CCK2Rhasalsobeenreportedinresponsetoitsperipheral
physiological ligand, gastrin (Takeuchi et al. 1979, 1980;
Nakajima et al. 2002; Gunther et al. 2003). Several
investigations have examined the association with disease
of polymorphisms in the CCK2R promoter (Hamilton
etal.2001;Hattorietal.2001),butlittleisgenerallyknown
about mechanisms of transcription. In the present study,
we used an in vivo model to examine expression of the
CCK2Rinresponsetogastricepithelialinjuryandinvitro
models to explore expression in response to cellular stress
and mechanisms of transcription.
Methods
Antibodies
Antibodies to CCK2R (SC33221) and β-actin were
from Santa Cruz (Autogen Bioclear, Calne, UK).
Afﬁnity-puriﬁed CCK2R antibody no.9491 was a
gift from DrG.V. Ohning (CURE Digestive Diseases
Research Center, Los Angeles, CA, USA). Antibodies
to vesicular monoamine transporter 2 (VMAT2), the
gastricH+,K+-ATPaseβ-subunit,desmin,smoothmuscle
α-actin and vimentin were from Research Diagnostics
(Flanders, NJ, USA). The glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) antibody was from AMS
(Abingdon, UK).
Chemicals
The CCK2R antagonist L740,093, the PKC inhibitor
Ro-32–0432 and the MEK inhibitor PD098059 were from
Calbiochem,Beeston,UK.Unsulphatedheptadecapeptide
gastrin was from Bachem (St. Helens, UK).
Cell culture
Human gastric adenocarcinoma cell lines AGS and AGS-
GR (stably transfected with the gastrin/CCK2R; Watson
et al. 2001) were maintained in F12–Ham’s medium
supplemented with 10% fetal bovine serum and 1%
penicillin–streptomycin solution (Sigma, Poole, UK).
The AGS-GR cells were maintained under selection by
supplementing medium with puromycin (2μgml −1)
every 4weeks. Rat gastric mucosa RGM1 and rat exocrine
pancreatic tumour AR42J cell lines were maintained
in Dulbecco’s modiﬁed Eagle’s medium (DMEM)–F12
supplemented with 10% fetal bovine serum and %
penicillin–streptomycin. All cells were maintained in a
humidiﬁed incubator at 37◦C under 5% CO2–95% O2.
Reporter constructs
A 1.7kb fragment of the CCK2R promoter was generated
by polymerase chain reaction (PCR) from human
genomic DNA. Forward and reverse primers spanned
the region from −1765 to −52bp upstream of the start
of translation, and incorporated KpnI and SacI sites,
respectively. The promoter fragment was cloned directly
into pGEM-Teasy (Promega, Southampton, UK), then
subclonedintothepromoterlessluciferasereportervector
pGL4.10 (Promega) between the KpnI and SacI sites to
generateCCK2R-1700.Asimilarstrategywasemployedto
generate a larger construct containing 4.5kb of promoter.
The 1.7kb construct was used as a template to generate
thedeletionalmutantsCCK2R-928,CCK2R-284,CCK2R-
196, CCK2R-130, CCK2R-103, CCK2R-71 and CCK2R-
48. Transverse mutations of the CCK2R-196 construct
weregenerateddirectlybyPCR,incorporatingappropriate
basesubstitutionsintheforwardprimer.Regionsmutated
were within consensus binding sites for C/EBPβ (CTGG
to AGTT), SP1 (GCGG to TATT) and GATA (GATA to
TCGC).
Transfections
For luciferase reporter experiments, AGS, AGS-GR or
RGM1 cells (2×106 per well) were plated into six-
well plates, 24h before transfection with either 1.0μg
CCK2R–luciferase constructs (AGS or RGM1) or empty
vector using 3μl Transfast (Promega) for 1h. The
AR42J cells (5×105) were plated into 12-well plates and
transfected with 2.0μg DNA per well using 1μl Polymag
(Oz Biosciences, Marseille, France); culture plates were
incubated at room temperature for 25min, placed on
the magnetic plate for a further 20min, then incubated
overnight at 37◦C with 2ml full serum medium per well.
To take account of non-speciﬁc changes in luciferase
activity, Renilla luciferase reporter vector (phRL-SV40;
Promega) was included in all transfections and the ratio
of ﬁreﬂy/Renilla luciferase activity calculated. Following
transfection, cells were maintained in full medium for
18hbeforestimulationwithgastrinorserumwithdrawal.
Luciferase activity was determined using a Lumat LB9507
luminometer (Berthold, Redbourne, UK) and a dual
luciferase assay system (Promega).
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Extraction of RNA and PCR
Total RNA was extracted from cell lines using TRIzol
(Invitrogen, Paisley, UK) according to the manufacturer’s
protocol. Residual contamination by genomic DNA
was eliminated by incubation of 10–100μgR N A
with 1Uμg−1 RNA deoxyribonuclease1 (Promega) in
10mmoll−1 Tris-HCl, pH8.3, 50mmoll−1 KCl and
1.5mmoll−1 MgCl2 for 30min at 37◦C. Samples of
DNAse-treated total RNA (2μg) from AGS-GR, AGS,
RGM1andAR42Jcellswerereversetranscribedusing20U
Avian myeloblastosis virus (AMV) reverse transcriptase
(Promega). For each RNA sample, reverse transcription
reactions were performed using 0.5μg of oligonucleotide
(dT) primer. The PCR ampliﬁcation was performed
on 1μl ﬁrst-strand cDNA using Taq DNA Polymerase
(Promega). For quantitative PCR, samples of total RNA
were treated for 30min at 37◦C with ribonuclease-free
deoxyribonuclease (1U(μgR N A ) −1; Promega) and then
extracted with acid phenol–chloroform and the aqueous
phase precipitated. The RNA pellets were reconstituted
in nuclease-free water, quantiﬁed, and 2μgr e v e r s e
transcribed using random hexamers. Real-time PCR
was performed using TaqMan primer–probe sets for rat
CCK2Rand18SrRNA(Eurogentec,Seraing,Belgium)on
an ABI Prism7700 sequence detection system (Applied
Biosystems, Warrington, UK). Expression of CCK2R and
18S rRNA in each sample was separately determined
using a standard curve method, and the CCK2R value
normalized to 18S in the same sample.
Western blotting
ProteinextractsfromRGM1andAR42Jcellswereprepared
in lysis buffer (McCaig et al. 2006) containing 1%
protease inhibitor cocktail setIII and 1% phosphatase
inhibitor cocktail setII (Calbiochem). Mice 10–12weeks
old were INS-GAS (Wang et al. 1996) or FVB, housed
in polycarbonate-bottomed cages with a strict light cycle
(lights on at 06.00 and off at 18.00h) and fed on a
commercial pellet diet with water ad libitum. Animals
were killed by increasing CO2 concentrations followed
by cervical dislocation. The stomach was removed and
a full thickness section of the corpus homogenized in
RIPAbuffer(UpstateBiotechnology,Cambridge,UK),and
Western blotting was performed as previously described
(Khan et al. 2003) using a rabbit anti-CCK2R antibody
(gift of DrG.V. Ohning). Membranes were reprobed
with a goat anti-actin antibody (Santa Cruz) or mouse
anti-GAPDH antibody (AMS). Expression of CCK2R
protein relative to actin or GAPDH in the same samples
was estimated by densitometry (Multi-Analyst; Bio-Rad,
Hemel Hempstead, UK).
Cryoinjury ulcer model in C57BL/6 mice
Animals used were 8- to 10-week-old female C57BL/6
mice, housed in polycarbonate-bottomed cages with a
strict light cycle (lights on at 06.00 and off at 18.00h)
and fed on a commercial pellet diet with water ad libitum.
Experimentalprotocolswereapprovedbytheinstitutional
animal welfare committee. Mice were anaesthetized by
isoﬂuorane inhalation, and the abdomen was incised
by a mid-line laparotomy. A cryoinjury was induced
on the ventral serosal surface of the gastric corpus by
applying, for 20s, a 2mm diameter stainless-steel probe
cooled in liquid nitrogen, and the abdomen closed. After
2, 6, 9 or 13days, the mice were killed by inhalation
of increasing CO2 concentrations followed by cervical
dislocation. Grossly visible damage to the mucosa was
identiﬁed, and gastric tissue was immediately ﬁxed in
4% paraformaldehyde for 1h at room temperature before
being transferred to 20% sucrose at 4◦C overnight. Tissue
was embedded in Cryo-M-Bed (Bright Instrument Co.
Ltd,Huntingdon,UK)andfrozento−40◦Cinisopentane.
Tissue was stored at −70◦C prior to sectioning. Serial
sections (10μm) were cut (−30◦C) using a cryostat
andthaw-mountedontopoly-l-lysine-coatedmicroscope
slides prior to immnunohistochemical staining or in
situ autoradiography. Sections were taken through the
cryoulcers and adjacent margins. For comparison with
normalgastrictissue,sectionsweretakenfrom0.5cmaway
from the ulcer site and from the opposite, dorsal wall of
the gastric corpus.
Immunohistochemistry
Immunohistochemistry was performed on frozen
sections. Primary antibodies [polyclonal rabbit
antihuman CCK2R (1:400, Santa Cruz); polyclonal
guinea-pig antibovine vimentin (1:200, RDI); mouse
monoclonal anti-smooth muscle α-actin (1:400); guinea-
pig polyclonal anti-VMAT2 (1:400); mouse monoclonal
anti-H+/K+-ATPase β subunit (1:1000); and rabbit
polyclonal anti-desmin (1:400)] were incubated at 4◦C
overnight. Thereafter, the slides were washed by stirring
in Tris-buffered saline containing 0.25% TritonX-100
three times for 10min at room temperature. The CCK2R
wasvisualizedwithﬂuoresceinisothiocyanate-conjugated
AfﬁniPure donkey antiserum raised against rabbit
immunoglobulinG (1:200; Jackson ImmunoResearch,
West Grove, PA, USA) and other antigens by Texas Red-
conjugatedAfﬁniPureantiseraappropriatetotheprimary
antiserum. Immunochemical staining was examined
with a ﬂuorescence microscope (Axioplan Universal, Carl
Zeiss, Welwyn Garden City, UK).
In situ hybridization
Cryostat sections (10μm) of paraformaldehyde-ﬁxed
stomach sections from control mice and mice with
cryoulcers were thawed and acetylated in 0.25m acetic
anhydride and 0.1m triethanolamide (10min). Sections
were dehydrated in 70–95% ethanol and stored in
95% ethanol at 4◦C overnight or used immediately.
Oligonucleotideprobescomplementarytobases540–585,
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887–932and2038–2083,relativetothestartoftranslation,
of the mouse CCK2R receptor (Eurogentec) were 3 
end-tailed with [35S]dATP (10mCiml−1; Amersham
Biosciences,LittleChalfont,UK),puriﬁedusingQIAquick
nucleotide removal columns (Qiagen, Crawley, UK),
and used at a concentration of 3000c.p.m.μl−1 in
hybridization buffer [50% formamide, 10% dextran
sulphate, SSPE (1×SSPE is composed of 3m NaCl,
0.2m NaH2PO4.2H2O and 0.2m EDTA, pH7.4),
0.2mgml−1 sheared salmon sperm DNA, 0.1mgml−1
polyA RNA, 5×Denhardt’s solution, and 20mm
dithiothreitol (DTT)]. Hybridization of each of the three
oligonucleotides independently or of all three CCK2R
oligonucleotidestogether(1:1:1)wasperformedovernight
at 42◦C; sections were washed in 1×standard saline
citrate (SSC) (150mm NaCI, 15mm sodium citrate,
pH7.0) at 55◦C (30min), 1×SSC 22◦C (30min),
0.1×SSC (30s), and dehydrated through ethanol, air
dried, dipped in autoradiographic emulsion (LM-1,
AmershamBiosciences),andexposedfor3–4weeksbefore
development. Sections were developed, counterstained
with Haematoxylin and Eosin, dehydrated, and mounted
usingDPX.SilvergrainswerevisualizedusinganAxioplan
Universal microscope, and images were processed using
AxioVision3.0 Imaging system (Zeiss) combined with
dark-ﬁeld and bright-ﬁeld illumination. In control slides,
100-foldexcessoftherelevantunlabelledoligonucleotides
were included in the hybridization.
Statistical analyses
Data are presented as means±s.e.m. Statistically
signiﬁcantdifferences(takenasP <0.05)weredetermined
by one-way ANOVA or Student’s unpaired t test as
appropriate.
Results
Endogenous expression of CCK2R in cell lines
ExpressionofendogenousCCK2RmRNAincelllineswas
initially determined by conventional reverse transcriptase
(RT)-PCR;AGS-GRcellspermanentlytransfectedwiththe
humanCCK2Rwereusedasapositivecontrol.Productsof
the anticipated size were detected in AGS-GR, RGM1 and
AR42J cells. Subsequent analyses were performed using
real time PCR (see below). We were unable to detect
expression in AGS cells not permanently transfected with
the receptor, or in IEC-6 cells derived from rat intestine.
Mechanism of basal CCK2R transcription
Transcription of the mouse CCK2R has been mapped
to 199bp upstream of the start of translation (Lay et al.
2000). For the human receptor, 185bp of 5  untranslated
cDNA have been described (Herget et al. 1994), which
agrees closely with the start of transcription annotated
on the National Center for Biotechnology Information
human genome database (193bp upstream of the start
of translation). The numbering of constructs used in
this study assumes that transcription (+1) starts 193bp
upstream of translation.
To determine the regions of the CCK2R promoter
requiredtosustainbasallevelsoftranscription,sequential
deletions of the promoter were generated from 1700 to
48bp. Truncation of the promoter from 1700 to 196bp
had little effect on basal transcription in AGS cells, but
further shortening to 130bp virtually abolished activity
(Fig. 1). The region −196 to −130 contains consensus
bindingsitesforthetranscriptionfactorsC/EBPβ,SP1and
GATA,andtoestablishtheirimportanceweindependently
mutated each of the three sites in CCK2R-196. Mutation
of each individual site signiﬁcantly reduced basal activity,
with maximal reduction of 74.8±5.4%, compared with
wild-type, seen in the SP1 mutant (Fig. 1). Similar data
were obtained when basal transcription was analysed in
RGM1 cells (Fig. 1).
Expression of CCK2R in response to serum deprivation
To establish whether endogenous CCK2R expression
might be altered in response to changes in the cellular
environment, we used real time PCR to determine
expression following withdrawal of growth factors by
serumstarvationofthecells.Whenserumwaswithdrawn
from cultured AR42J cells, CCK2R mRNA abundance
was doubled after 16h, increased 2.5-fold after 24h,
and was still elevated after 48h (Fig. 2). This increase
results at least in part from increased transcription, since
expression of a 1700bp promoter–reporter construct was
increased in response to withdrawal of serum for 24h
(control 100±10.0%; serum starvation, 184.8±31.3%,
P =0.013, n=3, Student’s unpaired t test). Elevation of
endogenous CCK2R mRNA abundance was also seen
in RGM1 cells deprived of serum for 24h (Fig. 2)
and, again, expression of a promoter–reporter construct
was signiﬁcantly increased (control 100±7.4%; serum
starvation, 167.7±25.1%, n=3, P =0.04, Student’s
unpaired ttest).
Gastrin-induced CCK2R expression
Gastrin has been reported to upregulate CCK2R
expression in the gastric surface mucus cell line GSM06
(Nakajima et al. 2002) and in pancreatic AR42J cells
(Gunther et al. 2003), in support of much earlier reports
that CCK2R expression in vivo might be regulated
by serum gastrin concentrations (Takeuchi et al. 1979,
1980). We used CCK2R promoter–reporter constructs
to determine whether gastrin could induce CCK2R
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transcription in AGS-GR cells and in the untransformed
celllineRGM1.InAGS-GR cells,gastrinincreasedCCK2R
expression in a dose-dependent manner over the range
10−10 to 5 ×10−9 m (Fig. 3). For 10−9 m gastrin, the
responsepeakedbetween2and4h,andcouldbeprevented
by the CCK2R antagonist L740,093 (Fig. 3). The response
togastrinwasalsoreducedinadose-dependentmannerby
the PKC inhibitor Ro-32–0432 and by the MEK inhibitor
PD098059 (Fig. 3).
Reductionofthepromoter–reporterconstructfrom4.5
to 1.7kb signiﬁcantly reduced the gastrin responsiveness
(4.5kb100±2.5%,1.7kb64.6±3.9%,n=3,P <0.0001,
ANOVA).Furtherreductionto775bpreducedthegastrin
responsivenessto50.8±1.5%thatofthe4.5kbconstruct,
butreductionfrom775to196bphadnoadditionaleffect.
tctcattcctgggaatcgggggtgggggcgggtgataaagagaggtgggcaggagagaaat
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Figure 1. Activity of CCK2R promoter–reporter constructs in gastric cell lines
A, sequence of the human CCK2R promoter −130 to −190 region, showing consensus cis-regulatory elements.
Numbering is relative to the start of transcription (+1), which is taken as 193 bp upstream of the start of translation
(see main text). B, basal activity of CCK2R promoter–reporter constructs (size as indicated) 24 h after transfection
in AGS cells. ∗ Signiﬁcantly reduced relative to 1700 bp construct (P < 0.001, n = 3, ANOVA). C, basal activity
of CCK2R promoter–reporter constructs (size as indicated) 24 h after transfection in RGM1 cells. ∗ Signiﬁcantly
reduced relative to 928 bp construct (P < 0.001, n = 3, ANOVA). D, basal activity of mutated 196 bp constructs
24 h after transfection into AGS cells. Mutations as indicated were made corresponding to the cis-regulatory
elements underlined in A. Values are percentage of wild-type (WT) sequence activity (= 100%). ∗ Signiﬁcantly
reduced compared with WT activity (P < 0.001, n = 3). E, basal activity of mutated 196 bp constructs 24 h
after transfection into RGM1 cells. Mutations as described in D. Values are percentage of WT sequence activity
(= 100%). ∗ Signiﬁcantly reduced compared with WT activity (P < 0.001, n = 3, ANOVA).
However,whentheC/EBPβ andSP1sitesweremutatedin
the 196bp construct, gastrin responsiveness was reduced
to 45.5±1.3 and 67.6±1.5% of the wild-type construct
(100±3.2%), respectively (P<0.002, ANOVA, n=3).
Mutations of the GATA site did not affect the response.
In RGM1 cells, G17 induced CCK2R expression at
the level of transcription, mRNA abundance and protein
abundance. Thus, expression of the 4.5kb promoter–
reporter construct was increased by G17 in a manner
that was sensitive to the CCK2R antagonist L740,093
(control 100±8.2%, G17 258±6.0%, G17+L740,093
148±11.1%, n=3). Endogenous CCK2R mRNA
abundance was also signiﬁcantly increased by gastrin in
RGM1 cells cultured for 6h in serum-free medium, and
was reduced in the presence of L740,093 (Fig. 4). The
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CCK2R protein was also signiﬁcantly increased when
RGM1 cells were exposed to gastrin (Fig. 4).
To determine whether the gastrin-stimulated CCK2R
expression observed in cell lines might be relevant in
vivo,weexaminedCCK2RexpressionbyWesternblotting
in a transgenic mouse (INS-GAS, Wang et al. 1996)
that expresses a gastrin transgene in pancreatic β cells
and that is hypergastrinaemic. In INS-GAS mice there
was a signiﬁcant elevation of gastric CCK2R expression
compared with wild-type control mice (Fig. 4).
Induction of CCK2R expression in gastric epithelium
following cryoulceration
In normal undamaged mucosa from the dorsal surface
of the gastric corpus, CCK2R-like immunoreactivity was
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Figure 2. Endogenous CCK2R mRNA abundance in response to
serum withdrawal from cell lines
A, endogenous CCK2R mRNA abundance in AR42J cells in response to
serum withdrawal for times indicated. Results are normalized to 18S
rRNA and are expressed as percentage of full serum value (= 100%).
n = 4. ∗P = 0.016, ∗∗P = 0.013, ∗∗∗P = 0.005 versus time 0, ANOVA.
B, CCK2R mRNA abundance in RGM1 cells in response to serum
withdrawal for times indicated. Results are normalized to 18S rRNA
and are expressed as percentage of full serum value (= 100%). n = 3.
∗P = 0.0016 versus time 0, ANOVA.
conﬁnedpredominantlytoepithelialcellsinthelowertwo-
thirds of the gastric glands, consistent with localization in
parietalcellsandECLcellsandcompatiblewithpreviously
published data (Kulaksiz et al. 2000; Schmassmann &
Reubi,2000;Khanetal.2003).Dualstainingwithantisera
against the β subunit of the gastric H+,K+-ATPase or
VMAT2 identiﬁed the CCK2R-expressing cells as parietal
cells and ECL cells, respectively (Fig. 5). Parietal cells in
the deeper regions of the gland generally expressed the
CCK2R, whereas those in the more superﬁcial regions
frequently did not (Fig. 5).
Two days after application of a cryoprobe to the
serosal surface of the gastric corpus, single cryoulcers
approximately 2mm diameter were macroscopically
visible in the mucosa, corresponding to the site of
cryoprobe application. Progressive repair of the ulcer
crater occurred at 6, 9 and 13days postinjury, and by
13days the mucosal ulceration was barely discernible
macroscopically. There was evidence of expansion of the
submucosal layer 6days after injury (Fig. 6).
Two days following cryoulcer generation, CCK2R-like
immunoreactivity at the ulcer margins remained similar
to that seen in non-damaged areas of stomach, consistent
with a previous report concerning CCK2R expression at a
singletimepointof2daysaftercryoulcergeneration(Khan
etal.2003).However,6,9and13daysfollowingcryoulcer
generation there was a progressive increase in CCK2R
immunoreactivity in regenerating mucosa adjacent to the
ulcer crater, maximal after 13days (Fig. 6).
Induction of CCK2R expression in gastric submucosal
layers following cryoulceration
In addition to the increased CCK2R expression in the
regenerative epithelium seen in response to cryoinjury,
there was also a time-dependent increase in CCK2R
immunoreactivity in cells within the submucosa.
Expression of CCK2R on submucosal cells was not
discernible after 2days, was maximal at 6–9days
and reduced by 13days, when the ulcer was mostly
healed, at least at the macroscopic level. No CCK2R
immunoreactivitywasobservedinthesubmucosaoftissue
away from the ulcer, at any time point (Fig. 6). Epithelial
or submucosal CCK2R expression was not seen when
primary antibody was omitted from the reactions (data
not shown). Moreover, the pattern of CCK2R expression
oncellswithinthemucosaandsubmucosawasconﬁrmed
by in situ hybridization (Fig. 7).
Identiﬁcation of CCK2R expression in myoﬁbroblasts
In order to determine which cell types express the
CCK2R within the mucosa and submucosa during
the repair process, dual immunohistochemistry was
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performed. Previous reports have suggested that the
CCK2R may be expressed on smooth muscle or smooth
muscle-like cell types in stomach (Reubi et al. 1997).
Consequently, 9day sections were dual stained with
CCK2R antibody together with antibodies to cell markers
of smooth muscle, ﬁbroblasts and myoﬁbroblasts. The
CCK2R immunopositive cells colocalized with vimentin
and with smooth muscle α-actin (Fig. 6). No desmin
immunoreactivity was observed in CCK2R-expressing
cells. Taken together, these data suggest novel expression
of the CCK2R on gastric myoﬁbroblasts in mucosa and
submucosa.
B
A
0
200
400
600
800
G17 - 100pM 1nM5 n M 10nM
*
**
**
p
e
r
c
e
n
t
 
u
n
s
t
i
m
u
l
a
t
e
d
 
r
e
s
p
o
n
s
e
0
100
200
300
p
e
r
c
e
n
t
 
u
n
s
t
i
m
u
l
a
t
e
d
 
r
e
s
p
o
n
s
e
*** *** ***
**
*
0 24 81 6 2 4
stimulation time (h)
D C
0
20
40
60
80
100
120
0
100
200
300
400
500
p
e
r
c
e
n
t
 
u
n
s
t
i
m
u
l
a
t
e
d
 
r
e
s
p
o
n
s
e
G17
L740,093
- +    +
--+
*
p
e
r
c
e
n
t
 
c
o
n
t
r
o
l
 
r
e
s
p
o
n
s
e
 
t
o
 
G
1
7
* *
**
** **
- 10nM    100nM     1µM          - - - Ro-32-0432
PD 098059 -- - - 2 0 0 n M     2 µM     20µM
Figure 3. Gastrin-stimulated CCK2R expression in AGS-GR cells
A, luciferaseactivityofa4.5 kbCCK2Rpromoter–reporterconstructinAGS-GR cells,6 hafterstimulationwithG17
at the doses indicated. Results are expressed as a percentage of the unstimulated response. n = 3. ∗P = 0.0034,
∗∗P < 0.0001 versus unstimulated control cells, ANOVA. B, luciferase activity of a 4.5 kb CCK2Rpromoter–reporter
construct in AGS-GR cells, after stimulation with G17 (1 nM) for the times indicated. Results are expressed as
a percentage of the unstimulated response. n = 3. ∗P = 0.0116, ∗∗P = 0.0002, ∗∗∗P < 0.0001 versus time 0,
ANOVA. C, luciferase activity of a 4.5 kb CCK2R promoter–reporter construct in AGS-GR cells, 6 h after stimulation
with G17 (1 nM) in the presence or absence of the CCK2R antagonist L740,093 (100 nM). Results are expressed
as a percentage of the unstimulated response. n = 3. ∗P = 0.0003 versus unstimulated control cells, ANOVA.
D, luciferase activity of a 4.5 kb CCK2R promoter–reporter construct in AGS-GR cells, 6 h after stimulation with
G17 (1 nM) in the presence of the PKC inhibitor Ro-32–0432 or the MEK inhibitor PD 098059, at the doses
indicated. Results are expressed as a percentage of the response to G17 in the absence of inhibitor (= 100%).
n = 3. ∗∗P < 0.0025, ∗P < 0.025 versus control cells, ANOVA.
Discussion
The present study identiﬁed endogenous expression of
the CCK2R in both transformed and untransformed cell
lines derived from the gastrointestinal tract. When cells
were stressed by withdrawal of serum, CCK2R expression
was upregulated, at least in part through transcriptional
activation. The expression of CCK2R in cell lines was
also upregulated by gastrin at close to physiological
concentrations, and the receptor was upregulated in vivo
intransgenicmicethatwerehypergastrinaemic.Innormal
gastric mucosa of C57BL/6 mice, CCK2R expression was
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restricted primarily to the epithelium, on parietal and
ECL cells. One to 2weeks following cryoulceration of the
mucosa, there was intense expression of CCK2R at the
repair margins of the ulcer and in the submucosa beneath
it, in cells that were identiﬁed as myoﬁbroblasts.
Numerous studies employing a variety of approaches
indicate that in the normal acid-secreting mucosa, the
CCK2R is expressed primarily on ECL and parietal cells
(Kopin et al. 1992; Prinz et al. 1993; Kulaksiz et al.
2000; Dockray et al. 2005), and this expression pattern
was conﬁrmed in the present study. The CCK2R plays
a major role in the physiological regulation of gastric
acid secretion, which is now believed to occur primarily
through gastrin-stimulated histamine release from the
ECL cell (Dockray et al. 2005). The importance for acute
regulation of acid secretion of the parietal cell CCK2R is
therefore open to question. Evidence is accumulating to
suggestinsteadthattheCCK2Rmaybecrucialforparietal
cell maturation and perhaps migration, as well as for the
releaseofanumberofparacrinemediators(Kohetal.1997;
Friis-Hansen et al. 1998; Kirton et al. 2002; Dimaline &
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Figure 4. Gastrin-stimulated CCK2R expression in RGM1 cells and in vivo
A, endogenous CCK2R mRNA abundance in RGM1 cells. Cells were cultured for 6 h in serum-free medium in
the presence or absence of G17 (1 nM) and the CCK2R antagonist L740,093 (100 nM). The abundance of CCK2R
mRNA was determined by real time PCR and normalized to 18S rRNA. Data are expressed as a percentage of the
unstimulated control cells. n = 3. ∗P < 0.0001 versus control cells; #P < 0.0001 versus G17 stimulated, ANOVA.
B, CCK2R protein expression in RGM1 cells. Cells were cultured for 6 h in serum-free medium in the presence or
absenceofG17(1 nM)andtheCCK2RantagonistL740,093(100 nM).TheCCK2RproteinwasdetectedbyWestern
blotting, and abundance estimated by densitometry and normalized to GAPDH. ∗P < 0.0001 versus control cells;
#P < 0.0001 versus G17 stimulated, ANOVA. C, Western blot of CCK2R (upper panel) and GAPDH (lower panel) in
gastric mucosa from INS-GAS (IG) and wild-type background (FVB) mice. Numbers to the left indicate size markers
(in kDa) run in the same gel. D, CCK2R protein abundance in the gastric mucosa from INS-GAS mice and their
wild-type background strain (FVB). Values, expressed as a percentage of the wild-type abundance, are normalized
to GAPDH. ∗P = 0.0014, Student’s unpaired t test, n = 8).
Varro, 2007). Studies on rabbit gastric glands provided
evidence for heterogeneity of the parietal cell population,
with the acid secretory capacity of cells near to the base of
theglandappearingtobelowerthanthatofthosefromthe
mid- or upper regions (Karam et al. 1997). Interestingly,
inthepresentstudy,colocalizationoftheCCK2Rwiththe
H+,K+-ATPaseβ subunitwasmarkedlygreaterinthebase
region of the gland, with much lower CCK2R expression
inparietalcellstowardsthemid-glandularregion.Itseems
plausible that this reﬂects a lesser role for the CCK2R in
the more active acid secretory population of parietal cells
and raises the possibility that it might also be involved in
regulatingnon-acidsecretoryfunctionsofthemoredeeply
situated parietal cell population.
The factors that regulate expression of the CCK2R
are not well known. Expression of the CCK2R is well
documentedinthepancreaticcancercelllineAR42J(Seva
etal.1994)andhasbeenreportedintheuntransformedrat
gastric mucosa-derived cell line RGM1 (Cui et al. 2006).
In the present study, we were able to detect endogenous
CCK2R expression at the level of both mRNA and protein
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in AR42J and RGM1 cells. Using luciferase–reporter
constructs we showed that a 196bp fragment of the
proximalpromoterwassufﬁcienttosupportbasalCCK2R
expression in RGM1 cells, and that consensus binding
sites for SP1, GATA and C/EBPβ were required for this
expression.SimilardatawereobtainedusingAGS-GRcells.
Putative binding sites for these transcription factors were
also identiﬁed in the proximal promoters of the rat and
mousegenesusingthetranscriptionelementsearchsystem
(TESS, http://www.cbil.upenn.edu/tess), suggesting that
they are likely to be important determinants of CCK2R
expression.
Several studies have sought associations between a CT
repeat polymorphism (conserved as CA repeats in the
rat and mouse promoters) that lies between 250 and
200bp upstream of the start of transcription and panic
disorder or schizophrenia (Kennedy et al. 1999; Hamilton
et al. 2001; Hattori et al. 2001). No clear association was
found and, in the present study, truncation of this region
had little or no effect on basal transcription in RGM1
Figure 5. Expression of CCK2R in normal corpus
A–C, CCK2R immunoreactivity in section of full-thickness gastric corpus. A,4  ,6-diamidino-2-phenylindole
(DAPI); B, CCK2R (ﬂuorescein isothiocyanate; FITC); and C, overlay. D–G, CCK2R and H+,K+-ATPase β subunit
immunoreactivity in gastric corpus. D, DAPI; E, CCK2R (FITC); F,H +,K+-ATPase β subunit (Texas Red); and G,
CCK2RandH+,K+-ATPaseβ subunitoverlay.H–K, CCK2RandVMAT2immunoreactivityingastriccorpus.H, DAPI;
I, CCK2R (FITC); J, VMAT2 (Texas Red); and K, CCK2R and VMAT2 overlay. Sections are representative of samples
obtained from four individual animals. For A–C, scale bar respresents 250 μm; for D–K, scale bar represents
200 μm.
or AGS cells. Increases in CCK2R expression were seen
in RGM1 and AGS cells in response to deprivation of
growth factors by serum withdrawal for more than about
8h. The response was at least in part due to changes
in transcription, since expression of reporter constructs
containing1.7kboftheCCK2Rpromoterwassigniﬁcantly
elevated in similar circumstances. The data are consistent
withtheideathatexpressionoftheCCK2Rmayrespondto
changesinthemicroenvironment,suchasthealterationof
growth factor proﬁles that might occur during responses
to inﬂammation or injury in vivo.
Studies from a number of years ago that correlated
serum gastrin concentrations with the capacity of gastric
mucosal membrane preparations to bind radiolabelled
G17 led to the suggestion that gastrin might stimulate
the production of its own receptor (Takeuchi et al. 1979,
1980). These ﬁndings remained unconﬁrmed for many
years, although support for the idea came from recent
studies using transgenic hypergastrinaemic mice and a pit
cell precursor line, which suggested that gastrin induced
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expression of the CCK2R in pit cell precursors (Nakajima
etal.2002).TransientexpressionoftheCCK2Rinresponse
to a relatively high concentration of G17 (10nm) has also
been reported in a PCR-based study using AR42J cells
(Gunther et al. 2003).
In the present study, we showed that gastrin increased
transcription of CCK2R promoter–reporter constructs
both in AGS-GR cells that are permanently transfected
with the CCK2R and in untransformed RGM1 cells that
endogenously express it. Transcription was signiﬁcantly
increased in a dose-dependent manner from 100pm
to 10nm G17, and increases in transcription were
detectable within 2h of stimulation. The response could
be completely prevented by a CCK2R antagonist, and was
reducedinadose-dependentmannerbyinhibitorsofPKC
andMEKtoaminimumofaround50%ofcontrolvalues.
Figure 6. Expression of CCK2R in gastric corpus following cryoulceration
A, CCK2R immunoreactivity and DAPI staining in full-thickness corpus 2, 6, 9 and 13 days following cryoulcer
generation. Note intense epithelial staining at ulcer repair margins at 13 days, and de novo staining in the
submucosa beneath the ulcer crater (indicated by white line) at 9 days. Scale bar represents 500 μM. Sections
are representative from four individual animals at each time point. B, CCK2R and smooth muscle α-actin immuno-
reactivity in gastric corpus epithelium at the repair margin of a 9 day ulcer. Upper panel, CCK2R (FITC); centre
panel, smooth muscle α-actin (Texas Red); and lower panel, overlay. C, CCK2R and vimentin immunoreactivity in
gastric corpus submucosa beneath the repairing crater of a 9 day ulcer. Upper panel, CCK2R (FITC); centre panel,
vimentin (Texas Red); and lower panel, overlay. D, deconvolved images of gastric corpus epithelial cells at the repair
margin of a 9 day ulcer. Upper left panel, CCK2R (FITC); upper right panel, smooth muscle α-actin (Texas Red); and
lower panel, overlay. E, deconvolved images of gastric corpus submucosal cells beneath the repairing crater of a
9 day ulcer. Upper panel, CCK2R (FITC); centre panel, vimentin (Texas Red); and lower panel, overlay. For B and C,
scale bar represents 50 μm; for D and E, scale bar respresents 10 μm.
Previous studies have shown that a number of CCK2R-
mediated increases in gene transcription are effected, at
leastinpart,throughPKC-andMEK-dependentpathways
(Hockeretal.1997;Watsonetal.2001;Raychowdhuryetal.
2002; Khan et al. 2003), and it seems this is also the case
for gastrin-stimulated CCK2R expression. As with basal
expression, the response was not dependent on the CT
polymorphic region, but did depend upon intact C/EBPβ
and SP1 sites in the proximal promoter. In RGM1 cells,
endogenousCCK2RmRNAabundanceandproteinlevels
wereelevatedaroundﬁvefoldinresponseto1nmG17,and
the response was in both cases signiﬁcantly attenuated by
a CCK2R antagonist.
To further address the relevance of these ﬁndings in
vivo, we determined expression of the CCK2R in the
stomach of a mouse model that has altered expression of
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the gastrin gene with consequential effects on circulating
gastrin concentrations. The INS-GAS mouse model
expresses a gastrin transgene in pancreatic β cells and is
hypergastrinaemic (Wang et al. 1996). In these animals,
a 50% increase in gastric CCK2R expression was seen
compared with wild-type FVB control mice. These data
are consistent with the notion that peripheral CCK2R
expression may be chronically regulated by gastrin and
provide support for earlier reports linking expression of
a functional gastrin receptor with circulating hormone
concentrations (Takeuchi et al. 1979, 1980).
Aside from its primary physiological expression in
ECL and parietal cells, a number of recent studies have
reported increased or de novo expression of the CCK2R
in other unspeciﬁed gastrointestinal cell types in some
experimental or clinical circumstances. For example,
expression was demonstrated by autoradiography in the
margins of cryoulcers induced in rats within 5days
of injury, and ulcer repair was enhanced by induction
of hypergastrinaemia (Schmassmann & Reubi, 2000).
The cell type in which the CCK2R was induced was
Figure 7. In situ hybridization of the CCK2R in gastric corpus
A, CCK2R expression in mucosa and submucosa 9 days following cryoulcer generation. Bracket indicates residual
ulcer crater. B, CCK2R expression in mucosa and submucosa 9 days following cryoulceration, 0.5 cm away from
the ulcer site. C, regenerative mucosa, adjacent to cryoulcer. D, submucosa below residual ulcer crater. E, normal
mucosa, 0.5 cm away from site of ulcer. F, normal submucosa, 0.5 cm away from site of ulcer. For A and B, scale
bar respresents 300 μm; for D–F, scale bar represents 50 μm. Hybridizations were performed using a mixture
(1:1:1) of the three oligonucleotides described in the Methods.
not identiﬁed, but they were presumed to be relatively
undifferentiated cells derived from progenitor cells.
Induction of CCK2R expression has been described in
proliferating cells in a transgenic mouse with a gastric
hyperproliferative phenotype (Nakajima et al. 2002).
Expression of a functional CCK2R was also increased
in the epithelium of Barrett’s metaplasia, compared
with unaffected individuals (Haigh et al. 2003), and in
the intestinal epithelium of mice following γ-radiation-
inducedinjury(Ottewelletal.2006).Takentogether,these
data suggest that upregulation of the CCK2R occurs in
a range of hyperproliferative conditions that are likely
to include inﬂammation or injury to the gastrointestinal
epithelium.
In a previous study, we reported that 2days after
cryoulceration of mouse gastric corpus mucosa, the
intensityanddistributionofCCK2Rexpressionwaslargely
unaltered from that seen in uninjured tissue (Khan et al.
2003), and these ﬁndings were conﬁrmed in the present
study.However,duringthesubsequentrepairoftheinjury,
there was a progressive increase in CCK2R expression
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in the mucosa at the ulcer margins that was maximal
after 13days. This time course of CCK2R expression is
consistent with that previously reported in rat gastric
mucosainresponsetocryoinjury(Schmassmann&Reubi,
2000). It seems plausible to suppose that a proportion
of the postinjury CCK2R-expressing cells are likely to
be relatively undifferentiated, as suggested previously
(Schmassmann & Reubi, 2000).
To further explore their identity, we performed
colocalization studies with markers of smooth muscle-
like cells. A substantial proportion of the cells that
expressed the CCK2R, 9days after cryoinjury, also
expressed vimentin and smooth muscle α-actin but not
desmin, which strongly suggests they are likely to be
myoﬁbroblasts.Myoﬁbroblastsareakeymesenchymalcell
type.Ingastricglands,theyareincloseassociationwiththe
neck or isthmus region and are thought to be important
determinants of the stem cell niche, e.g. by secretion
of growth factors and cytokines (Spradling et al. 2001;
Leedhametal.2006;McCaigetal.2006;Dimaline&Varro,
2007). Whilst it might not, therefore, be surprising to see
increased myoﬁbroblast numbers in regions undergoing
rapidregenerationofgastricglands,theyhavenothitherto
been reported to express the CCK2R. Cells expressing
vimentin were sparse in uninjured mucosa and showed
little or no colocalization with CCK2R.
In addition to the increased mucosal postinjury
expression of the CCK2R at the ulcer margins, intense
areas of expression were seen in the submucosa beneath
and adjacent to the ulcer that were maximal at 6–9days
and had largely disappeared by 13days. A signiﬁcant
proportion of these CCK2R-expressing submucosal cells
were again identiﬁed as myoﬁbroblasts on the basis of
coexpression of vimentin and smooth muscle α-actin.
It is well established that myoﬁbroblasts have important
functions in the response to inﬂammation and injury in
thegastrointestinaltractandelsewhere(Powelletal.1999;
Jacksonetal.2000;Dimaline&Varro,2007).Theoriginof
myoﬁbroblasts generated in response to injury is to some
extentdependentuponthenatureofthepathologyandthe
organsystemaffected.Commonly,theydifferentiatefrom
ﬁbroblasts, although transdifferentiation from epithelial
cellsorothermesenchymalcelltypesispossible(Hinzetal.
2007).Therelationshipbetweenthemyoﬁbroblastsseenin
submucosaandmucosainthepresentstudyisunclear.The
earlier appearance in submucosa may be a consequence
of the nature of cryoulceration, where the initial site of
the injury is the serosal surface of the stomach. It seems
possiblethatsomeofthemyoﬁbroblastsappearinglaterin
the mucosa may have migrated from the submucosa.
The mechanisms that lead to de novo expression of
the CCK2R by myoﬁbroblasts in response to ulceration
of the gastric mucosa presently remain unclear. The
functionalconsequencesofsuchexpressionalsoremainto
beestablished.Inarecentreport(Varroetal.2007),gastrin
wasdemonstratedtostimulatemyoﬁbroblastproliferation
indirectly via release of matrix metalloproteinase7 from
epithelial cells. The present data suggest that in response
to inﬂammation or injury, gastrin might act directly on
myoﬁbroblastsfollowinginductionofCCK2Rexpression,
tofurtherenhanceepithelial–mesenchymalinteractions.
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